Table I.
Clinical characteristics of HT patients and healthy controls enrolled in the present study.
| Characteristics | Control | Hashimoto's thyroiditis |
|---|---|---|
| N (male/female) | 51 (20/31) | 389 (71/318) |
| Mean age | 47.59±12.38 | 46.70±13.34 |
| TPOAb, IU/ml (IQR) | 29.85 (27.35–31.73) | 89.13 (38.53–355.30)a |
| TgAb, IU/ml (IQR) | 27.01 (19.9–30.55) | 214.9 (48.62–540.00)a |
| TSH, mIU/l (IQR) | 2.06 (1.61–3.19) | 4.02 (2.40–5.98)a |
| FT4, pmol/l | 14.92±1.81 | 13.88±2.86 |
| FT3, pmol/l | 5.39±0.44 | 5.20±0.69 |
a
P≤0.001 vs. control subjects. TPOAb, anti-thyroid peroxidase antibody; TgAb, anti-thyroid globulin antibody; TSH, thyroid stimulating hormone; FT4, free thyroxine; FT3, free triiodothyronine; IQR, interquartile range.